Rani Therapeutics (RANI) Insider Trading & Ownership → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free RANI Stock Alerts $5.55 -0.23 (-3.98%) (As of 01:10 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Rani Therapeutics (NASDAQ:RANI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage53.30%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$77,540.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$10.58 M Get RANI Insider Trade Alerts Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RANI Insider Buying and Selling by Quarter Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" Rani Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/6/2023Talat ImranCEOBuy10,000$2.27$22,700.00 12/4/2023Talat ImranCEOBuy5,000$2.57$12,850.00 11/29/2023Talat ImranCEOBuy20,000$2.05$41,000.00 11/24/2023Cortes Isidoro Alfonso QuirogaMajor ShareholderSell5,265,165$2.01$10,582,981.65 11/16/2023Maulik NanavatyDirectorBuy500$1.98$990.00 (Data available from 1/1/2013 forward) RANI Insider Trading Activity - Frequently Asked Questions Who is on Rani Therapeutics's Insider Roster? The list of insiders at Rani Therapeutics includes Cortes Isidoro Alfonso Quiroga, Maulik Nanavaty, Mir A Imran, South Cone Investments Limited, and Talat Imran. Learn more on insiders at RANI. What percentage of Rani Therapeutics stock is owned by insiders? 53.30% of Rani Therapeutics stock is owned by insiders. Learn more on RANI's insider holdings. Which Rani Therapeutics insiders have been buying company stock? The following insiders have purchased RANI shares in the last 24 months: Cortes Isidoro Alfonso Quiroga ($259,948.60), Maulik Nanavaty ($990.00), South Cone Investments Limited ($1,293,643.82), and Talat Imran ($76,550.00). How much insider buying is happening at Rani Therapeutics? Insiders have purchased a total of 274,627 RANI shares in the last 24 months for a total of $1,631,132.42 bought. Which Rani Therapeutics insiders have been selling company stock? The following insiders have sold RANI shares in the last 24 months: Cortes Isidoro Alfonso Quiroga ($10,582,981.65), and Mir A Imran ($853,881.28). How much insider selling is happening at Rani Therapeutics? Insiders have sold a total of 5,345,417 Rani Therapeutics shares in the last 24 months for a total of $11,436,862.93 sold. More Insider Trading Tools from MarketBeat Related Companies: TERN Insider Selling ERAS Insider Selling HROW Insider Selling NATR Insider Selling ADCT Insider Selling AMRN Insider Selling ANRO Insider Selling PGEN Insider Selling ATAI Insider Selling NKTX Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:RANI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.